Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in antineoplastic therapy.

M M Gullatte1, T Graves

  • 1Emory University Hospital, Atlanta, GA.

Oncology Nursing Forum
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

New antineoplastic agents offer improved cancer treatment with reduced toxicity. Recent drug analogues enhance therapeutic index, potentially improving patient tolerance and treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A genomic case study of mixed fibrolamellar hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Effectiveness of a group opt-in session on uptake and graduation rates for pulmonary rehabilitation.

Chronic respiratory disease·2010
Same author

Genomics. Genome project standards in a new era of sequencing.

Science (New York, N.Y.)·2009
Same author

Cancer support groups: meeting the needs of African Americans with cancer.

Seminars in oncology nursing·2001
Same author

Surveying Saccharomyces genomes to identify functional elements by comparative DNA sequence analysis.

Genome research·2001
Same author

Office-based surgery and cost avoidance in an obstetrics and gynecology residency program.

The American journal of managed care·2000
Same journal

Exploring Information Needs of Patients With Cancer and Family Caregivers: A Descriptive and Network Analysis of End-of-Life Inquiries.

Oncology nursing forum·2026
Same journal

Postoperative Physiologic Comfort Management for Patients With Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy.

Oncology nursing forum·2026
Same journal

Exploring Racial Disparities in Uterine Cancer Survival: A 20-Year, Single-Site Analysis.

Oncology nursing forum·2026
Same journal

What I See as an Editor: The Reach of Nurse-Led Intervention Oncology Research.

Oncology nursing forum·2026
Same journal

Trends and Hot Spots in Cancer Family Resilience: A Bibliometric and Visualization Study.

Oncology nursing forum·2026
Same journal

Seven-Year Cognitive Trajectories in Older Adult Cancer Survivors: Findings From a National Cohort Study.

Oncology nursing forum·2026
See all related articles

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Discovery

Background:

  • Cancer remains a significant health concern with high mortality rates despite diagnostic and therapeutic advances.
  • Existing antineoplastic agents like cisplatin and etoposide (VP-16) have been pivotal in cancer therapy.
  • There is an ongoing need for novel antineoplastic drugs with broader activity and reduced side effects.

Purpose of the Study:

  • To review recent developments in antineoplastic drug therapy.
  • To highlight the emergence of analogues of existing chemotherapy drugs.
  • To discuss the potential benefits of these new agents in cancer treatment.

Main Methods:

  • Literature review of recent advancements in antineoplastic drug development.
  • Analysis of the therapeutic index and toxicity profiles of new drug analogues.

Related Experiment Videos

  • Examination of the potential for combination therapies involving novel agents.

    • Main Results:

    • Analogues of existing antineoplastic agents have been developed and marketed.
    • These new drugs demonstrate an enhanced therapeutic index.
    • Reduced toxicity is a key feature of these analogues, potentially improving patient tolerance.

    Conclusions:

    • Recent analogues of established antineoplastic agents represent a significant advancement in cancer treatment.
    • These drugs offer improved efficacy and safety profiles compared to older agents.
    • The development of these analogues may lead to better patient outcomes and enhanced tolerance to chemotherapy.